[73] found that agonist activation of PPARγ synergistically increases the growth-inhibitoryeffect of the platinum-based drugs cisplatin and carboplatin in severaldifferent types of cancers in both in vivo and in vitro studies. The gene discussed is PPARG; the disease is cancer.